Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 5, 2026

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
05:19

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

1.7K

Postsurgical Cystoid Macular Edema.

Dinah Zur, Anat Loewenstein

    Developments in Ophthalmology
    |March 29, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Cystoid macular edema (CME) can impair vision after eye surgery. Topical anti-inflammatories and corticosteroids are first-line treatments for postsurgical CME, with other options for persistent cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    RetiMap: Automated Retinal Vascular Measures Link Microvascular Structure to Metabolic Health and Predict Cardiovascular Risk.

    JACC. Basic to translational science·2026
    Same author

    Intraocular Pressure Outcomes with Intravitreal Aflibercept 8 mg: A 96-Week Pooled Analysis from PULSAR and PHOTON.

    Ophthalmology and therapy·2026
    Same author

    Artificial intelligence and medical retina training: A scoping review of educational opportunities, emerging risks, and curricular responses.

    Survey of ophthalmology·2026
    Same author

    Insights into age-related macular degeneration.

    Handbook of clinical neurology·2026
    Same author

    Endophthalmitis rates following intravitreal injection of aflibercept using a prefilled syringe - a multicenter study.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
    Same author

    Peripapillary Choroidal Neovascularization in Adults: Spectrum of Etiologies and Clinical Features.

    Investigative ophthalmology & visual science·2026
    Same journal

    Erratum.

    Developments in ophthalmology·2021
    Same journal

    Pediatric Vitreoretinal Surgery and Integrated Intraoperative Optical Coherence Tomography.

    Developments in ophthalmology·2021
    Same journal

    Integrated Intraoperative Optical Coherence Tomography for Pediatric Lamellar Corneal Transplant Surgery.

    Developments in ophthalmology·2021
    Same journal

    The Use of Optical Coherence Tomography as an Intraoperative Adjunct of Oculoplastic Surgery.

    Developments in ophthalmology·2021
    Same journal

    Integrated Intraoperative Optical Coherence Tomography in Strabismus Surgery.

    Developments in ophthalmology·2021
    Same journal

    Use of Integrated Intraoperative Ocular Coherence Tomography in Pediatric Cataract Surgery: Thinking outside the Box.

    Developments in ophthalmology·2021
    See all related articles

    Area of Science:

    • Ophthalmology
    • Retinal Diseases
    • Surgical Complications

    Background:

    • Cystoid macular edema (CME) is a significant cause of vision loss post-cataract and vitreoretinal surgery.
    • Incidence of clinical CME after modern cataract surgery ranges from 0.1-2.35%.
    • Risk factors include diabetes mellitus, uveitis, and intraoperative complications; etiology remains partly unclear.

    Purpose of the Study:

    • To review the characteristics, diagnosis, and management of cystoid macular edema (CME).
    • To discuss differential diagnoses and treatment strategies for pseudophakic CME.

    Main Methods:

    • Review of literature on cystoid macular edema (CME).
    • Discussion of diagnostic tools like fluorescein angiography and optical coherence tomography (OCT).

    More Related Videos

    Endoscopic Approach for Colloid Cyst Resection
    02:30

    Endoscopic Approach for Colloid Cyst Resection

    Published on: May 23, 2025

    942
    Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
    04:59

    Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

    Published on: July 7, 2023

    3.1K

    Related Experiment Videos

    Last Updated: Mar 5, 2026

    Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
    05:19

    Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

    Published on: December 1, 2023

    1.7K
    Endoscopic Approach for Colloid Cyst Resection
    02:30

    Endoscopic Approach for Colloid Cyst Resection

    Published on: May 23, 2025

    942
    Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
    04:59

    Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

    Published on: July 7, 2023

    3.1K
  • Analysis of treatment options including topical NSAIDs, corticosteroids, oral agents, and surgical interventions.

    • Main Results:

    • Pseudophakic CME presents with reduced visual acuity and characteristic OCT findings.
    • Differential diagnoses include age-related macular degeneration and diabetic macular edema.
    • Most cases resolve spontaneously; prophylactic treatment efficacy is uncertain.

    Conclusions:

    • First-line treatment for postsurgical CME involves topical NSAIDs and corticosteroids.
    • Oral carbonic anhydrase inhibitors and periocular/intraocular corticosteroids are options for resistant cases.
    • Antiangiogenic agents and surgery are reserved for specific, nonresponsive persistent CME scenarios.